Autologous umbilical cord blood infusion for type 1 diabetes

2006, Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999, Diabet Med, 23, 857, 10.1111/j.1464-5491.2006.01925.x Vehik, 2007, Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth, Diabetes Care, 30, 503, 10.2337/dc06-1837 Karvonen, 2000, Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group, Diabetes Care, 23, 1516, 10.2337/diacare.23.10.1516 Eeg-Olofsson, 2007, Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register, Diabetes Care, 30, 496, 10.2337/dc06-1406 Haller, 2007, Type 1 diabetes intervention trials 2007: where are we and where are we going?, Curr Opin Endocrinol Diabetes Obes, 14, 283, 10.1097/MED.0b013e32825a673b Schatz, 2003, Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination, Diabetes Care, 26, 3326, 10.2337/diacare.26.12.3326 Limbert, 2008, Beta-cell replacement and regeneration: strategies of cell-based therapy for type 1 diabetes mellitus, Diabetes Res Clin Pract, 79, 389, 10.1016/j.diabres.2007.06.016 Hussain, 2004, Stem-cell therapy for diabetes mellitus, Lancet, 364, 203, 10.1016/S0140-6736(04)16635-X Couri, 2006, Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration, Braz J Med Biol Res, 39, 1271, 10.1590/S0100-879X2006001000002 Ende, 2004, Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice, Biochem Biophys Res Commun, 325, 665, 10.1016/j.bbrc.2004.10.091 Haller, 2007, Insulin requirements, HbA1c, and stimulated C-peptide following autologous umbilical cord blood transfusion in children with type 1 diabetes, A82 Viener, 2007, Changes in regulatory T cells following autologous umbilical cord blood transfusion in children with type 1 diabetes, A82 Voltarelli, 2007, Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus, JAMA, 297, 1568, 10.1001/jama.297.14.1568 Bach, 2001, Tolerance to islet autoantigens in type 1 diabetes, Annu Rev Immunol, 19, 131, 10.1146/annurev.immunol.19.1.131 Atkinson, 1999, The NOD mouse model of type 1 diabetes: as good as it gets?, Nat Med, 5, 601, 10.1038/9442 Rapoport, 1993, Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation, J Exp Med, 177, 1221, 10.1084/jem.177.4.1221 Gombert, 1996, Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, Eur J Immunol, 26, 2989, 10.1002/eji.1830261226 Lederman, 1981, Defective suppressor cell generation in juvenile onset diabetes, J Immunol, 127, 2051, 10.4049/jimmunol.127.5.2051 Asano, 1996, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation, J Exp Med, 184, 387, 10.1084/jem.184.2.387 Salomon, 2000, B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes, Immunity, 12, 431, 10.1016/S1074-7613(00)80195-8 Wu, 2002, Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice, Proc Natl Acad Sci U S A, 99, 12287, 10.1073/pnas.172382999 Liu, 2002, Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter, J Immunol, 169, 581, 10.4049/jimmunol.169.1.581 Chatenoud, 2001, Suppressor T cells—they're back and critical for regulation of autoimmunity!, Immunol Rev, 182, 149, 10.1034/j.1600-065X.2001.1820112.x Serreze, 1993, Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice, J Immunol, 150, 2534, 10.4049/jimmunol.150.6.2534 Alleva, 2000, Diabetes, 49, 1106, 10.2337/diabetes.49.7.1106 Dahlen, 2000, Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation, J Immunol, 164, 2444, 10.4049/jimmunol.164.5.2444 Kukreja, 2002, Multiple immuno-regulatory defects in type-1 diabetes, J Clin Invest, 109, 131, 10.1172/JCI0213605 Weaver, 2001, Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase, J Immunol, 167, 1461, 10.4049/jimmunol.167.3.1461 Yan, 2003, Impaired processing and presentation by MHC class II proteins in human diabetic cells, J Immunol, 170, 620, 10.4049/jimmunol.170.1.620 Pavlakis, 2007, Pancreas and islet cell transplantation in diabetes, Curr Opin Endocrinol Diabetes Obes, 14, 146, 10.1097/MED.0b013e32807f2ac8 Bottino, 2003, Gene- and cell-based therapeutics for type I diabetes mellitus, Gene Ther, 10, 875, 10.1038/sj.gt.3302015 Beilhack, 2003, Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice, Diabetes, 52, 59, 10.2337/diabetes.52.1.59 Hess, 2003, Bone marrow-derived stem cells initiate pancreatic regeneration, Nat Biotechnol, 21, 763, 10.1038/nbt841 Lennard, 2000, Stem cell transplantation, BMJ, 321, 433, 10.1136/bmj.321.7258.433 Marmont, 1997, Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases, J Rheumatol Suppl, 48, 13 Raetz, 1997, Treatment of severe Evans syndrome with an allogeneic cord blood transplant, Bone Marrow Transplant, 20, 427, 10.1038/sj.bmt.1700907 Comi, 2000, Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group, J Neurol, 247, 376, 10.1007/s004150050605 Fruchtman, 2003, Stem cell transplantation, Mt Sinai J Med, 70, 166 Brunstein, 2007, Expanding the role of umbilical cord blood transplantation, Br J Haematol, 137, 20, 10.1111/j.1365-2141.2007.06521.x Harris, 2007, The potential of cord blood stem cells for use in regenerative medicine, Expert Opin Biol Ther, 7, 1311, 10.1517/14712598.7.9.1311 Denner, 2007, Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin, Cell Prolif, 40, 367, 10.1111/j.1365-2184.2007.00439.x Han, 1995, Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation, Br J Haematol, 89, 733, 10.1111/j.1365-2141.1995.tb08409.x Porter, 2006, Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs, Transplantation, 82, 23, 10.1097/01.tp.0000225824.48931.af Li, 2005, CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy, Blood, 106, 3068, 10.1182/blood-2005-04-1531 Brusko, 2007, Treg in type 1 diabetes, Cell Biochem Biophys, 48, 165, 10.1007/s12013-007-0018-5